Resultados de la búsqueda 311-320 de 3905 para anti-TNF drugs
abril 2024. DEA Drug Take Back Day at Mayo Clinic in Florida April 23, 2024, 02:30 p.m. CDT · Mayo Clinic Minute: Creating an advance directive for your future ...
... treatment or non-treatment (placebo) arm. Participants in the treatment arm will take the supplement drug for 2 days. For all participants, an olive-sized ...
Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Establishment of Preclinical Models from Patients with ...
The purpose of this study is to assess how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning ...
The PPCR will collect demographic and clinical data which many centers that deliver proton radiation therapy already collect in routine operations. Dabrafenib ...
... treatment participants get is decided by chance. Semaglutide is a medicine, doctors can prescribe in some countries for the treatment of type 2 diabetes.
The purpose of this study is to assess how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment ...
This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come back (recurrent).
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?